Oventus Financial News Network Interview

20:00 EDT 23 Aug 2017 | BioSpace

Brisbane, Aug 24, 2017 - (ABN Newswire) - Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network. In the interview, Dr Hart discusses Oventus' three products cleared with the US FDA and the agreement with Modern Dental Group, the largest manufacturer and distributor of dental prost...

Original Article: Oventus Financial News Network Interview


More From BioPortfolio on "Oventus Financial News Network Interview"

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...